---

---

sector : Professional, scientific, and technical services    entities : Emmaus life sciences, inc.   

save search

---

Emmaus Life Sciences Reports Delayed Filing of Annual Report
Published: 2024-04-15 (Crawled : 20:00) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| Email alert Add to watchlist
report life sciences

---

Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
Published: 2024-02-02 (Crawled : 15:00) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -15.09% | O: 22.64% H: 0.0% C: 0.0%
life authorization sciences

---

Emmaus Life Sciences Reports Q3 2023 Financial Results
Published: 2023-11-14 (Crawled : 14:30) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -25.0% | O: 0.0% H: 0.0% C: 0.0%
life sciences financial results

---

Emmaus Life Sciences Reports Management Changes
Published: 2023-08-23 (Crawled : 14:00) - biospace.com/
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| Email alert Add to watchlist
management life sciences

---

Emmaus Life Sciences Receives Endari® Marketing Authorization from the Bahrain NHRA
Published: 2023-05-31 (Crawled : 21:00) - biospace.com/
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -66.04% | O: 13.21% H: 6.67% C: 6.67%
endari life authorization sciences

---

Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update
Published: 2023-05-15 (Crawled : 16:00) - biospace.com/
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -71.88% | O: 0.0% H: 0.0% C: 0.0%
business life update sciences financial results

---

Amarin Urges Shareholders to Vote “Against” Sarissa’s Harmful Proposals at Upcoming General Meeting – IT HAS NO PLAN, NO NEW IDEAS AND AN UNDERQUALIFIED SLATE
Published: 2023-02-17 (Crawled : 14:00) - globenewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -81.25% | O: -4.17% H: 0.0% C: -4.24%
IRWD | $8.31 3.1% 390K |

Health Technology

| -28.99% | O: 1.5% H: 4.38% C: 2.86%
INVA | $15.14 1.41% 87K |

Health Technology

| 22.48% | O: 0.82% H: 1.55% C: 1.06%
AMRN | News | $0.8801 1.66% 230K |

Health Technology

| -53.48% | O: 0.53% H: 0.0% C: -2.13%
ARMP | $2.44 -2.79% 7.5K |

Health Technology

| -8.06% | O: -0.37% H: 5.69% C: 2.21%
meeting

---

Global Hemoglobinopathies Market Report 2022: Rising Cases in Under-Developed Countries Boosts Growth
Published: 2023-01-16 (Crawled : 14:00) - prnewswire.com
ALNY | $148.99 2.2% 130K |

Health Technology

| Email alert Add to watchlist
PFE | News A | $26.32 0.23% 4.4M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 600K |

Health Technology

| Email alert Add to watchlist
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| Email alert Add to watchlist
ABT | News | $107.565 0.46% 610K |

Health Technology

| Email alert Add to watchlist
DHR | $252.325 6.88% 2.6M |

Health Technology

| Email alert Add to watchlist
GBT | $68.49 0.02% -0.02% |

Health Technology

| Email alert Add to watchlist
SNY | News | $47.375 0.48% 300K |

Health Technology

| Email alert Add to watchlist
global report growth market

---

Dr. Niihara Meets with Local Indian Governor
Published: 2022-12-20 (Crawled : 15:20) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -72.73% | O: 3.03% H: 6.35% C: 6.35%

---

Dr. Niihara Feted by Indian Government in Recognition of the Development of Endari®
Published: 2022-12-19 (Crawled : 15:20) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -72.73% | O: 9.09% H: 0.0% C: -8.33%
endari

---

Endari® Receives Kuwaiti Marketing Authorization
Published: 2022-12-07 (Crawled : 20:00) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -76.92% | O: 0.0% H: 0.0% C: -12.56%
endari authorization

---

Global Hemoglobinopathies Market Report to 2031 - Featuring Abbott Laboratories, Alnylam Pharmaceuticals, Biogen Idec and Bluebird Among Others
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -73.4% | O: 33.02% H: 0.0% C: -21.11%
ARVL | News | $0.49 0.37% 2.5M |

Manufacturing

| 33.97% | O: -5.8% H: 0.0% C: 0.0%
NVS | News | $98.12 3.15% 1.1M |

Health Technology

| 10.58% | O: 0.74% H: 0.89% C: 0.53%
DHR | $252.325 6.88% 2.6M |

Health Technology

| -9.43% | O: -0.32% H: 1.21% C: 0.09%
ABT | News | $107.565 0.46% 610K |

Health Technology

| 3.08% | O: -0.13% H: 1.13% C: 0.14%
SNY | News | $47.375 0.48% 300K |

Health Technology

| 4.65% | O: 1.02% H: 0.0% C: 0.0%
SGMO | News | $0.5506 7.94% 810K |

Health Technology

| -86.03% | O: -1.1% H: 1.66% C: -0.28%
ALNY | $148.99 2.2% 130K |

Health Technology

| -32.93% | O: 0.22% H: 2.19% C: -5.13%
global report market

---

Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update
Published: 2022-11-15 (Crawled : 01:00) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -76.0% | O: 6.67% H: 0.0% C: -25.0%
sciences life financial update results

---

Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update
Published: 2022-11-14 (Crawled : 00:00) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -76.0% | O: 6.67% H: 0.0% C: -25.0%
sciences life financial update results

---

Sickle Cell Disease Treatment Market to Garner USD 1.6 Billion by 2031: Allied Market Research
Published: 2022-11-10 (Crawled : 01:00) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -75.68% | O: -18.92% H: 15.0% C: 15.0%
NVS | News | $98.12 3.15% 1.1M |

Health Technology

| 14.22% | O: 2.81% H: 0.43% C: -0.2%
treatment research disease market

---

Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari®
Published: 2022-09-28 (Crawled : 11:00) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -40.0% | O: 6.67% H: 25.0% C: 25.0%
endari sciences disease collaboration life

---

Emmaus Life Sciences Reports Q2 2022 Financial Results and Provides Business Update
Published: 2022-08-15 (Crawled : 21:00) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -75.68% | O: -9.46% H: 10.45% C: 10.45%
sciences life update results

---

Emmaus Life Sciences Announces Engagement of Strategic Business Relations and Professional Services Advisor
Published: 2022-07-12 (Crawled : 14:20) - prnewswire.com
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -78.44% | O: 0.0% H: 0.0% C: -4.19%
sciences services life

---

Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business Update
Published: 2022-05-13 (Crawled : 18:00) - biospace.com/
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -71.88% | O: -5.94% H: 15.95% C: -16.54%
sciences results

---

Emmaus Life Sciences Presented Positive Real-World Data on the Efficacy of Endari® in Preventing Acute Complications from Sickle Cell Disease at the 62nd Annual Scientific Meeting of the British Society for Haematology
Published: 2022-04-07 (Crawled : 13:00) - biospace.com/
EMMA | $0.0921 66K |

Professional, Scientific, and T...

| -90.53% | O: -2.11% H: 0.0% C: -13.98%
endari disease positive

---

Gainers vs Losers

89%

11%

Top 10 Gainers

MTTR | News M | $4.65 167.24% 9.8M |

AGBA | $2.355 88.4% 34M |

Finance

EDBL | News | $6.75 79.52% 1.5M |

CZOO | $8.77 75.75% 11M |

VNRX | $0.84 40.0% 2.6M |

Health Technology

OPRT | News | $3.01 33.78% 6.8M |

Finance

MLEC | $1.81 29.29% 2M |

n/a

CMAX | $4.12 28.35% 65K |

Manufacturing

MTC | $2.0 28.21% 1.7M |

Technology Services

PEGY | $0.0586 27.95% 130M |

Manufacturing

---

Your saved searches

---